{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:47:59Z","timestamp":1784630879793,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejphar.2020.173440","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T21:26:25Z","timestamp":1596230785000},"page":"173440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["In vitro and in vivo characterization of Lu AA41178: A novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disorders"],"prefix":"10.1016","volume":"887","author":[{"given":"Morten","family":"Grupe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Hjorth","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tau","family":"Benned-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Sindal","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Skibsbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette Graven","family":"Sams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Grunnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rottl\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Frank","family":"Bastlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173440_bib1","doi-asserted-by":"crossref","first-page":"8821","DOI":"10.1523\/JNEUROSCI.2225-08.2008","article-title":"Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events","volume":"28","author":"Aragona","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173440_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(95)00292-S","article-title":"Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine","volume":"283","author":"Arnt","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173440_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0773.1982.tb01032.x","article-title":"Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade","volume":"51","author":"Arnt","year":"1982","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2020.173440_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev-pharmtox-010617-052912","article-title":"KCNQ-encoded potassium channels as therapeutic targets","volume":"58","author":"Barrese","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2020.173440_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41593-018-0152-y","article-title":"What does dopamine mean?","volume":"21","author":"Berke","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173440_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/epi.13634","article-title":"Progress report on new antiepileptic drugs: a summary of the thirteenth eilat conference on new antiepileptic drugs and devices (eilat xiii)","volume":"58","author":"Bialer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2020.173440_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000317525","article-title":"Differential effects of ICA-27243 on cloned KV7 channels","volume":"86","author":"Blom","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2020.173440_bib8","doi-asserted-by":"crossref","first-page":"16453","DOI":"10.1523\/JNEUROSCI.3177-10.2010","article-title":"Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action","volume":"30","author":"Cao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173440_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng0198-53","article-title":"A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family","volume":"18","author":"Charlier","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2020.173440_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2013.03.039","article-title":"Characterization of a novel high-potency positive modulator of K(v)7 channels","volume":"709","author":"Dalby-Brown","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173440_bib11","doi-asserted-by":"crossref","first-page":"11671","DOI":"10.1038\/ncomms11671","article-title":"KCNQ channel openers reverse depressive symptoms via an active resilience mechanism","volume":"7","author":"Friedman","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2020.173440_bib12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1021\/jm901497b","article-title":"Novel KCNQ2\/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain","volume":"53","author":"Fritch","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173440_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471141755.ph0522s45","article-title":"Acute seizure tests in epilepsy research: electroshock- and chemical-induced convulsions in the mouse","volume":"45","author":"Giardina","year":"2009","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173440_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0306-4522(88)90307-7","article-title":"Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry","volume":"24","author":"Gonon","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173440_bib15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173440_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00018-016-2359-y","article-title":"Modulation of Kv7 channels and excitability in the brain","volume":"74","author":"Greene","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2020.173440_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2011.03365.x","article-title":"The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy","volume":"53","author":"Gunthorpe","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2020.173440_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s13311-017-0527-x","article-title":"Neural substrates of depression and resilience","volume":"14","author":"Han","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2020.173440_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2007.05.029","article-title":"The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine","volume":"570","author":"Hansen","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173440_bib20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/jpet.106.106757","article-title":"The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat","volume":"318","author":"Hansen","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173440_bib21","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1113\/jphysiol.2007.149450","article-title":"Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS","volume":"586","author":"Hansen","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2020.173440_bib22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1517\/17460441.2013.837882","article-title":"The preclinical discovery and development of ezogabine for the treatment of epilepsy","volume":"8","author":"Jankovic","year":"2013","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173440_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npp.2017.68","article-title":"Ethanol withdrawal drives anxiety-related behaviors by reducing M-type potassium channel activity in the lateral habenula","volume":"42","author":"Kang","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173440_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3570549","article-title":"Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice","volume":"7","author":"Kimball","year":"1957","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ejphar.2020.173440_bib25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.105.083923","article-title":"Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels","volume":"314","author":"Korsgaard","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173440_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1152\/jn.00574.2005","article-title":"Characterization of M-current in ventral tegmental area dopamine neurons","volume":"96","author":"Koyama","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2020.173440_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173440_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1528-1167.2011.03364.x","article-title":"The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use","volume":"53","author":"Large","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2020.173440_bib29","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/bph.14026","article-title":"Selective targeting of M-type potassium Kv7.4 channels demonstrates their key role in the regulation of dopaminergic neuronal excitability and depression-like behaviour","volume":"174","author":"Li","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173440_bib30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0026-895X(24)12344-9","article-title":"Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission","volume":"61","author":"Otto","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173440_bib31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/aps.2017.72","article-title":"Pharmacological modulation of the voltage-gated neuronal Kv7\/KCNQ\/M-channel alters the intrinsic excitability and synaptic responses of pyramidal neurons in rat prefrontal cortex slices","volume":"38","author":"Peng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2020.173440_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbr.2008.12.027","article-title":"Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania","volume":"198","author":"Redrobe","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2020.173440_bib33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/jpet.108.137794","article-title":"In vivo profile of ICA-27243 [N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2\/Q3 (Kv7.2\/Kv7.3) activator in rodent anticonvulsant models","volume":"326","author":"Roeloffs","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173440_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0920-1211(95)00101-8","article-title":"D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures","volume":"23","author":"Rostock","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2020.173440_bib35","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0128-05.2005","article-title":"Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine","volume":"25","author":"Schenzer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173440_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0198-25","article-title":"A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns","volume":"18","author":"Singh","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2020.173440_bib37","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1093\/brain\/awg286","article-title":"KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum","volume":"126","author":"Singh","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2020.173440_bib38","first-page":"951","article-title":"Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl) carbamic acid ester], a KCNQ potassium channel opener","volume":"328","author":"Sotty","year":"2009","journal-title":"via Modulation of Mesolimbic Dopaminergic Neurotransmission"},{"key":"10.1016\/j.ejphar.2020.173440_bib39","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41380-018-0283-2","article-title":"Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder","volume":"25","author":"Tan","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173440_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2020.173440_bib41","unstructured":"Torn\u00f8e, C.W., Khanzhin, N., Rottl\u00e4nder, M., Watson, W.P., Greve, D.R., 2006. Substituted pyridine derivatives. patent (WO2006092143A1)."},{"key":"10.1016\/j.ejphar.2020.173440_bib42","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173440_bib43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1124\/mol.107.043216","article-title":"N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2\/Q3 potassium channel activator","volume":"73","author":"Wickenden","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173440_bib44","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1523\/JNEUROSCI.0765-04.2004","article-title":"KCNQ\/M channels control spike afterdepolarization and burst generation in hippocampal neurons","volume":"24","author":"Yue","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173440_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2016.11.024","article-title":"Acute stress diminishes M-current contributing to elevated activity of hypothalamic-pituitary-adrenal axis","volume":"114","author":"Zhou","year":"2017","journal-title":"Neuropharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992030532X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992030532X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:40:23Z","timestamp":1757976023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992030532X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":45,"alternative-id":["S001429992030532X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173440","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo characterization of Lu AA41178: A novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173440"}}